SITUATION A global pharma company needed to create a registry of multiple myeloma patients in order to run an eight-year observational study. The study, which involved 5,000 patients across 18 countries, required a solution that was engaging enough to maintain patient participation for such an extended period of time, and that notified them when it was time to complete quarterly assessments — without influencing their behavior. An electronic solution was preferred over paper as the pharma company believed paper would increase the burden on patients, raise the risk of erroneous data entries and delay reporting. SOLUTION ERT's Post-Approval platform enabled the development of a ‘light touch’ web portal accessible through patients’ own devices (laptop, tablet, phone). This Bring-Yo

Join for free to read